1. Home
  2. SEZL vs DNTH Comparison

SEZL vs DNTH Comparison

Compare SEZL & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sezzle Inc.

SEZL

Sezzle Inc.

HOLD

Current Price

$153.89

Market Cap

4.5B

Sector

Finance

ML Signal

HOLD

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

HOLD

Current Price

$103.87

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEZL
DNTH
Founded
2016
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Financial Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
4.5B
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
SEZL
DNTH
Price
$153.89
$103.87
Analyst Decision
Buy
Strong Buy
Analyst Count
6
13
Target Price
$109.33
$121.00
AVG Volume (30 Days)
600.7K
1.1M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.47
N/A
Revenue
$450,279,000.00
$2,036,000.00
Revenue This Year
$30.30
N/A
Revenue Next Year
$24.79
$29.48
P/E Ratio
$108.17
N/A
Revenue Growth
66.08
N/A
52 Week Low
$49.50
$18.08
52 Week High
$195.71
$107.99

Technical Indicators

Market Signals
Indicator
SEZL
DNTH
Relative Strength Index (RSI) 45.42 58.23
Support Level $60.73 $89.21
Resistance Level $190.36 N/A
Average True Range (ATR) 12.49 5.76
MACD -4.44 0.25
Stochastic Oscillator 1.30 72.73

Price Performance

Historical Comparison
SEZL
DNTH

About SEZL Sezzle Inc.

Sezzle Inc is a financing institution that offers technology-driven payment platform. The Sezzle Platform offers a payments solution for consumers in the United States and Canada that has the ability to instantly extend credit at the point-of-sale, allowing consumers to purchase and receive merchandise while paying in installments over time. Consumers pay a portion of the purchase price at the point-of-sale as a down payment, and then pay off the remaining amount over time through scheduled payments. It also offer the ability to pay-in-full using the Sezzle Platform. Its operations comprise one reportable segment, the majority of which derives revenue from payment processing platform in North America.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

Share on Social Networks: